As of 2025-07-01, the EV/EBITDA ratio of Affimed NV (AFMD) is -0.12. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AFMD's latest enterprise value is 7.18 mil USD. AFMD's TTM EBITDA according to its financial statements is -61.80 mil USD. Dividing these 2 quantities gives us the above AFMD EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 2.4x - 3.1x | 3.0x |
| Forward P/E multiples | 2.7x - 4.3x | 3.4x |
| Fair Price | (49.23) - (55.55) | (57.65) |
| Upside | -27226.5% - -30703.4% | -31862.3% |
| Date | EV/EBITDA |
| 2025-06-26 | -0.09 |
| 2025-06-25 | -0.09 |
| 2025-06-24 | -0.09 |
| 2025-06-23 | -0.09 |
| 2025-06-20 | -0.09 |
| 2025-06-18 | -0.09 |
| 2025-06-17 | -0.09 |
| 2025-06-16 | -0.09 |
| 2025-06-13 | -0.09 |
| 2025-06-12 | -0.09 |
| 2025-06-11 | -0.09 |
| 2025-06-10 | -0.09 |
| 2025-06-09 | -0.09 |
| 2025-06-06 | -0.09 |
| 2025-06-05 | -0.09 |
| 2025-06-04 | -0.09 |
| 2025-06-03 | -0.09 |
| 2025-06-02 | -0.09 |
| 2025-05-30 | -0.09 |
| 2025-05-29 | -0.09 |
| 2025-05-28 | -0.09 |
| 2025-05-27 | -0.09 |
| 2025-05-23 | -0.09 |
| 2025-05-22 | -0.09 |
| 2025-05-21 | -0.09 |
| 2025-05-20 | -0.09 |
| 2025-05-19 | -0.10 |
| 2025-05-16 | -0.10 |
| 2025-05-15 | -0.09 |
| 2025-05-14 | -0.10 |
| 2025-05-13 | -0.10 |
| 2025-05-12 | -0.13 |
| 2025-05-09 | -0.13 |
| 2025-05-08 | -0.13 |
| 2025-05-07 | -0.13 |
| 2025-05-06 | -0.13 |
| 2025-05-05 | -0.14 |
| 2025-05-02 | -0.14 |
| 2025-05-01 | -0.15 |
| 2025-04-30 | -0.15 |
| 2025-04-29 | -0.15 |
| 2025-04-28 | -0.14 |
| 2025-04-25 | -0.14 |
| 2025-04-24 | -0.14 |
| 2025-04-23 | -0.13 |
| 2025-04-22 | -0.13 |
| 2025-04-21 | -0.13 |
| 2025-04-17 | -0.13 |
| 2025-04-16 | -0.13 |
| 2025-04-15 | -0.13 |